Champions Oncology, Inc.

Champions Oncology, Inc. is a contract research organization (CRO) specializing in oncology drug development, offering clinically relevant patient-derived xenograft (PDX) and primary tumor models, comprehensive ex vivo and in vivo testing platforms, and multi‑omic data services. The company provides lab and clinical specialty testing — including flow cytometry, next‑generation sequencing, histology/IHC, proteomics, and radiopharmaceutical testing — together with bioinformatics and the Lumin data platform to help pharmaceutical and biotech partners select models, predict responses, and accelerate translational research. Its living tumor bank and curated multi‑omics dataset support target and biomarker discovery and early drug development programs worldwide.